| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | 2G86QN327L |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Tympanic Membrane Perforation | 3 | D018058 | ClinicalTrials |
| Hypovolemia | 3 | D020896 | ClinicalTrials |
| Edema | 2 | D004487 | ClinicalTrials |
| Leukemia, Promyelocytic, Acute | 2 | D015473 | ClinicalTrials |
| Hepatitis C | 1 | D006526 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Carcinoma, Medullary | 1 | D018276 | ClinicalTrials |
| Vaginosis, Bacterial | 0 | D016585 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 9000-70-8 |
| ChEMBL | CHEMBL2108518 |
| FDA SRS | 2G86QN327L |
CONTENTS